Advertisement

Sport Sciences for Health

, Volume 14, Issue 2, pp 459–462 | Cite as

Topical sevoflurane: analgesic management in a marathon runner with plantar fasciitis

  • F. Dámaso Fernández-GinésEmail author
  • Manuel Cortiñas-Sáenz
  • Ana Navajas-Gómez de Aranda
  • Francisco Sierra-García
Case Report

Abstract

We present a case of a Caucasian adult marathon runner with a 3-month history of severe unilateral pain in the left heel. Magnetic resonance imaging showed an enthesitis of the plantar fascia. His baseline VAS score was 1/10, but this increased to 7/10 post-exercise, and not alleviated by non-invasive treatments. Initially, patient-directed treatments consisting of rest, ice massage, oral analgesics, diclofenac gel, and stretching techniques for several weeks. His primary goal was to return to running marathons without symptoms. A sevoflurane 0.5% gel preparation was topically applied in the affected area at doses of 0.25–0.5 mL/cm2, resulting in a pain-free region shortly after the application (VAS score 0/10), thus enabling normal physical activity for up to 60 min, without further damage to the plantar fascia. The novel use of topical sevoflurane gel in the management of PF pain is reported and discussed herein.

Keywords

Plantar fasciitis Heel pain Painful heel syndrome Topical drug Sevoflurane 

Notes

Compliance with ethical standards

Conflict of interest

The authors have declared no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

All of the subjects provided written consent to participate in the study, after the study procedure and methods were explained to them.

Additional information

The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation, and were included in work submitted by Mr. F. Dámaso Fernández-Ginés as part of requirements of the doctorate program in pharmacy at the University of Granada, Granada, Spain.

References

  1. 1.
    Kumai T, Samoto N, Hasegawa A et al (2017) Short-term efficacy and safety of hyaluronic acid injection for plantar fasciopathy. Knee Surg Sports Traumatol Arthrosc.  https://doi.org/10.1007/s00167-017-4467-0 PubMedCrossRefGoogle Scholar
  2. 2.
    Goff JD, Crawford R (2011) Diagnosis and treatment of plantar fasciitis. Am Fam Physician 84(6):676–682PubMedGoogle Scholar
  3. 3.
    Thomas JL, Christensen JC, Kravitz SR, American College of Foot and Ankle Surgeons Heel Pain Committee et al (2010) The diagnosis and treatment of heel pain: a clinical practice guideline-revision 2010. J Foot Ankle Surg 49(3 suppl):S1–S19CrossRefPubMedGoogle Scholar
  4. 4.
    Munegato D, Gridavilla G, Guerrasio S et al (2017) Mini open versus open repair techniques in Achilles tendon rupture: clinical and isokinetic evaluation. Muscles Ligaments Tendons J 7(3):554–561.  https://doi.org/10.11138/mltj/2017.7.3.554 CrossRefPubMedGoogle Scholar
  5. 5.
    Karabay N, Toros T, Hurel C (2007) Ultrasonographic evaluation in plantar fasciitis. J Foot Ankle Surg 46(6):442–446CrossRefPubMedGoogle Scholar
  6. 6.
    McPoil TG, Martin RL, Cornwall MW, Wukich DK, Irrgang JJ, Godges JJ (2008) Heel pain—plantar fasciitis: clinical practice guidelines linked to the international classification of function, disability, and health from the orthopaedic section of the American Physical Therapy Association. J Orthop Sports Phys Ther 38(4):A1–A18CrossRefPubMedGoogle Scholar
  7. 7.
    Sawynok J (2014) Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. Eur J Pain 18:465–481CrossRefPubMedGoogle Scholar
  8. 8.
    Asbill S, Sweitzer SM, Signers Romero-Sandoval A (2014) Compounded pain formulations: what is the evidence? Int J Pharm Compd 18:278–286PubMedGoogle Scholar
  9. 9.
    Martínez-Monsalve A, GerónimoPardo M (2011) Analgesic effect of topical sevoflurane on ischaemic wound in a patient with ischaemic cardiopathy and respiratory failure secondary to morphine. H&C 6:46–49Google Scholar
  10. 10.
    MartínezMonsalve A, GerónimoPardo M (2013) The Analgesic effect of topical sevoflurane on painful varicose ulcers in ambulatory patients. H&C 1:16–19Google Scholar
  11. 11.
    Fernández-Ginés FD, Cortiñas-Sáenz M, Fernández Sánchez C, Morales-Molina J (2017) Topical sevoflurane: a new palliative therapeutic option for skin ulcers. MEDIPAL 24:104–108.  https://doi.org/10.1016/j.medipa.2015.03.003 CrossRefGoogle Scholar
  12. 12.
    Fernández-Ginés D, Cortiñas-Sáenz, Mateo-Carrasco et al (2017) Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers: a pilot study. Am J Health Syst Pharm 74(9):e176–e182.  https://doi.org/10.2146/ajhp151008
  13. 13.
    Imbernón-Moya A, Blázquez C, Puebla A et al (2016) Chronic venous ulcer treatment with topical sevoflurane. Int Wound J 13(5):1060–1062.  https://doi.org/10.1111/iwj.12474 CrossRefGoogle Scholar
  14. 14.
    GerónimoPardo M, MartínezMonsalve A, Martínez Serrano M (2011) Analgesic effect of topical sevoflurane on venous leg ulcer with intractable pain. Phlebologie 40:95–97CrossRefGoogle Scholar
  15. 15.
    Othman AM, Ragab EM (2010) Endoscopic plantar fasciotomy versus extracorporeal shock wave therapy for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 130(11):1343–1347CrossRefPubMedGoogle Scholar
  16. 16.
    Weil LS, Roukis TS, Weil LS, Borrelli AH (2002) Extracorporeal shock wave therapy for the treatment of chronic plantar fasciitis: indications, protocol, intermediate results, and a comparison of results to fasciotomy. J Foot Ankle Surg 41(3):166–172CrossRefPubMedGoogle Scholar
  17. 17.
    Fassoulaki A, Sarantopoulus C, Karabinis G, Derveniotis C (1998) Skin application of isoflurane attenuates the responses to a mechanical and a electrical stimulation. Can J Anaesth 45:1151–1155CrossRefPubMedGoogle Scholar
  18. 18.
    Barkin RL (2013) The pharmacology of topical analgesics. Postgrad Med 125:7–18CrossRefPubMedGoogle Scholar
  19. 19.
    Thorlacius K, Bodelsson M (2004) Sevoflurane promotes endothelium-dependent smooth muscle relaxation in isolated human omental arteries and veins. Anesth Analg 99:423–428CrossRefPubMedGoogle Scholar
  20. 20.
    Placzek R, Deuretzbacher G, Buttgereit F, Meiss AL (2005) Treatment of chronic plantar fasciitis with botulinum toxin A: an open case series with a 1 year follow up. Ann Rheum Dis 64(11):1659–1661CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ahmad J, Ahmad SH, Jones K (2017) Treatment of plantar fasciitis with botulinum toxin. Foot Ankle Int 38(1):1–7CrossRefPubMedGoogle Scholar
  22. 22.
    Kalaci A, Cakici H, Hapa O, Yanat AN, Dogramaci Y, Sevinc TT (2009) Treatment of plantar fasciitis using four different local injection modalities: a randomized prospective clinical trial. J Am Podiatr Med Assoc 99(2):108–113CrossRefPubMedGoogle Scholar
  23. 23.
    Liden B, Simmons M, Landsman AS (2009) A retrospective analysis of 22 patients treated with percutaneous radiofrequency nerve ablation for prolonged moderate to severe heel pain associated with plantar fasciitis. J Foot Ankle Surg 48:642–647CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Complejo Hospitalario TorrecardenasAlmeríaSpain

Personalised recommendations